These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30701823)

  • 1. Case of iatrogenic botulism after botulinotherapy in clinical practice.
    Ibatullin RA; Magjanov RV
    Ter Arkh; 2018 Nov; 90(11):102-104. PubMed ID: 30701823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic botulism after botulinum toxin type A injections.
    Coban A; Matur Z; Hanagasi HA; Parman Y
    Clin Neuropharmacol; 2010 May; 33(3):158-60. PubMed ID: 20150804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulism-like syndrome after injections of botulinum toxin.
    Cobb DB; Watson WA; Fernandez MC
    Vet Hum Toxicol; 2000 Jun; 42(3):163. PubMed ID: 10839321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A Descriptive Series of Patient Features and Outcome.
    Rashid EAMA; El-Mahdy NM; Kharoub HS; Gouda AS; ElNabarawy NA; Mégarbane B
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):622-627. PubMed ID: 29786953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation.
    Chertow DS; Tan ET; Maslanka SE; Schulte J; Bresnitz EA; Weisman RS; Bernstein J; Marcus SM; Kumar S; Malecki J; Sobel J; Braden CR
    JAMA; 2006 Nov; 296(20):2476-9. PubMed ID: 17119144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature.
    Ghasemi M; Norouzi R; Salari M; Asadi B
    Clin Neuropharmacol; 2012; 35(5):254-7. PubMed ID: 22986799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic botulism in a child with spastic quadriparesis.
    Partikian A; Mitchell WG
    J Child Neurol; 2007 Oct; 22(10):1235-7. PubMed ID: 17940253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.
    Bakheit AM; Ward CD; McLellan DL
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):198. PubMed ID: 9048725
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
    Gonul Oner O; Gudek HC; Erturk Cetin O; Demir S
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):82-84. PubMed ID: 36728838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature.
    Leonardi L; Haggiag S; Petrucci A; Lispi L
    J Clin Neurosci; 2019 Feb; 60():138-141. PubMed ID: 30348587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iatrogenic botulism in therapeutic use of botulinum toxin].
    Berntsen M; Bøgevig S; Høgberg LCG; Barnung SK
    Ugeskr Laeger; 2022 Feb; 184(7):. PubMed ID: 35179113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practice of botulism].
    Ikeguchi K
    Brain Nerve; 2011 Jul; 63(7):763-73. PubMed ID: 21747147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Takotsubo-like Myocardial Dysfunction in a Patient with Botulism.
    Tonomura S; Kakehi Y; Sato M; Naito Y; Shimizu H; Goto Y; Takahashi N
    Intern Med; 2017 Nov; 56(21):2925-2927. PubMed ID: 28924131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis.
    Tugnoli V; Eleopra R; Quatrale R; Capone JG; Sensi M; Gastaldo E
    Br J Dermatol; 2002 Oct; 147(4):808-9. PubMed ID: 12366438
    [No Abstract]   [Full Text] [Related]  

  • 16. Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach
    Floresta G; Patamia V; Gentile D; Molteni F; Santamato A; Rescifina A; Vecchio M
    ChemMedChem; 2020 Jan; 15(2):256-262. PubMed ID: 31774239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis for respiratory failure in patients with food-borne botulism.
    Witoonpanich R; Vichayanrat E; Tantisiriwit K; Wongtanate M; Sucharitchan N; Oranrigsupak P; Chuesuwan A; Nakarawat W; Tima A; Suwatcharangkoon S; Ingsathit A; Rattanasiri S; Wananukul W
    Clin Toxicol (Phila); 2010 Mar; 48(3):177-83. PubMed ID: 20184431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulism: the challenge of diagnosis and treatment.
    Brook I
    Rev Neurol Dis; 2006; 3(4):182-9. PubMed ID: 17224901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulism: a rare complication of injecting drug use.
    Wenham TN
    Emerg Med J; 2008 Jan; 25(1):55-6. PubMed ID: 18156552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulism Due to Cosmetic Injection of Botulinum Toxin: Five-Year Experience.
    Carruthers JD; Fagien S
    Plast Reconstr Surg; 2022 Sep; 150(3):695e. PubMed ID: 35816088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.